Veterinary Medicine Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2032
7.1%
CAGR (2025-2032)
36.11 USD Bn.
Market Size
330
Report Pages
161
Market Tables
Overview
The Veterinary Medicine Market size was valued at USD 36.11 Billion in 2024 and the total Veterinary Medicine revenue is expected to grow at a CAGR of 7.1% from 2025 to 2032, reaching nearly USD 62.51 Billion.
Veterinary Medicine Market Dynamics
The MMR report includes various segments as well as an analysis of the trends and growth factors that are playing a substantial role in the market. These factors the market dynamics involve the drivers, restraints, opportunities, and challenges. Such as, The rise in the occurrence of contagious diseases among animals is driving the market for veterinary drugs. Animals also play a crucial role in research and development in studying drug therapy by performing preclinical trials in animals to develop advance drug and cost-effective veterinary drugs. Moreover, increasing awareness towards livestock and to cure zoonotic and chronic disease drives the market, rapid urbanization and an increase in per capita income drive the market growth.
To know about the Research Methodology :- Request Free Sample Report
However, the discovery of complex diseases and various infections in humans from animals through the consumption of animal products such as bird flu, bird flu, rabies, coronova virus, and others and not giving street animals appropriately treatment restraints the market growth.
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Veterinary Medicine Market Opportunities:
Growing research and development investment to develop more effective drugs
Rising meat consumption across the globe and animal-derived product like ghee, milk, butter give a better opportunity.
Veterinary Medicine Market: Market Segment Analysis:
The report covers the brief analytical segments of the veterinary medicine market thereby providing a wider view at the macro as well as micro levels. By route of administration, parenteral is dominating the veterinary medicine market and valued around US$ xx Bn in . Parenteral administration is more preferred over other as it gives rapid onset of action, The better bioavailability, and reliable dosage and it gives fast therapeutic effect with rapid onset of action as it overcomes the first-pass metabolism whereas, several adverse reactions and painful delivery and discomfort are the drawbacks and hinder the growth.
Pharmacies & drug stores segment is projected to witness the fastest growth during the forecast period. Because of the requirement and urgency in clinical for targeted medicines and to protect from zoonotic diseases and livestock animals.
Regional analysis:
North America’s Veterinary medicine market was valued at US$ xx million in 2024 and is expected to reach a value of US$ xx million by 2032, with a CAGR of xx%. The major factors which are driving the growth of the Veterinary medicine market in the regions as it provides good animal welfare policies and its spend huge expenditure on research in market especially the U.S and Canada. Since, North America is the developed region it consists of advance veterinary hospital and the large healthcare players and hence, take part in growing the economics of the market.
Europe is considered the second most promising market after North America in the Advancement of new techniques and growing healthcare agencies the European market is undertaken by Germany and Frances and so, drives the European market.
Veterinary Medicine Market Recent Development
In June 2018, Merck entered into a business with Vinovo B.V a division of Viscon Hatchery Automation. This has aided the company increase its portfolio of poultry vaccines.
The objective of the report is to present a comprehensive analysis of the Global Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
Veterinary Medicine Market Scope : Inquire before buying
| Global Veterinary Medicine Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2024 | Forecast Period: | 2025-2032 |
| Historical Data: | 2019 to 2024 | Market Size in 2024: | USD 36.11 Bn. |
| Forecast Period 2025 to 2032 CAGR: | 7.1% | Market Size in 2032: | USD 62.51 Bn. |
| Segments Covered: | by Product | Drugs Vaccines Medicated Feed Additives |
|
| by Route of Administration | Oral Parenteral Topical |
||
| by Application | Companion Animals Livestock Animals |
||
| by End-User | Veterinary Hospital Veterinary Clinics Pharmacies & Drug Stores |
||
Veterinary Medicine Market, by Region:
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
key Players:
1. Agrovet Market Animal Health
2. American Veterinary Clinic
3. Animalcare
4. BASF India Ltd
5. Belfarmacom
6. Bimeda
7. Biotex Plus Ltd
8. Boehringer Ingelheim Gmbh
9. Brouwer
10. Cadila Pharmaceuticals Ltd
11. Cargill India Pvt. Ltd
12. Ceva
13. Chemo Argentina
14. Koninklijke DSM N.V
15. Mars
16. Merck & Co.
17. Saudi Pharmaceutical Industries
18. Sauvet
19. Selecta
20. Syntec
21. The British Veterinary Center
22. UCBVET
23. Vetanco
24. Veterinarski Zavod Subotica
25. Vetmedica
26. Wageningen Bioveterinary Research
27. Wilbur-Ellis
28. Zoetis
Frequently Asked Questions:
1. Which region has the largest share in Global Veterinary Medicine Market?
Ans: North America region held the highest share in 2024.
2. What is the growth rate of Global Veterinary Medicine Market?
Ans: The Global Veterinary Medicine Market is expected to grow at a CAGR of 7.1% during forecast period 2025-2032.
3. What is scope of the Global Veterinary Medicine market report?
Ans: Global Veterinary Medicine Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Veterinary Medicine market?
Ans: The important key players in the Global Veterinary Medicine Market are – Agrovet Market Animal Health, American Veterinary Clinic, Animalcare, BASF India Ltd, Belfarmacom, Bimeda, Biotex Plus Ltd, Boehringer Ingelheim Gmbh, Brouwer, Cadila Pharmaceuticals Ltd, Cargill India Pvt. Ltd, Ceva, Chemo Argentina, Koninklijke DSM N.V, Mars, Merck & Co., Saudi Pharmaceutical Industries, Sauvet, Selecta, Syntec, The British Veterinary Center, UCBVET, Vetanco, Veterinarski Zavod Subotica, Vetmedica, Wageningen Bioveterinary Research, Wilbur-Ellis and Zoetis.
5. What was the Global Veterinary Medicine Market size in 2024?
Ans: The Global Veterinary Medicine Market size was USD 36.11 Billion in 2024.
Table of Contents
Global Veterinary Medicine Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Veterinary Medicine Market Size, by Market Value (US$ Bn) & Volume (Unit)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Veterinary Medicine Market Analysis and Forecast
6.1. Global Veterinary Medicine Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Veterinary Medicine Market Analysis and Forecast, By Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Veterinary Medicine Market Value Share Analysis, By Product
7.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Product
7.5. Global Veterinary Medicine Market Analysis, By Product
7.6. Global Veterinary Medicine Market Attractiveness Analysis, By Product
8. Global Veterinary Medicine Market Analysis and Forecast, By Route of Administration
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Veterinary Medicine Market Value Share Analysis, By Route of Administration
8.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Route of Administration
8.5. Global Veterinary Medicine Market Analysis, By Route of Administration
8.6. Global Veterinary Medicine Market Attractiveness Analysis, By Route of Administration
9. Global Veterinary Medicine Market Analysis and Forecast, By End-User
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Veterinary Medicine Market Value Share Analysis, By End-User
9.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By End-User
9.5. Global Veterinary Medicine Market Analysis, By End-User
9.6. Global Veterinary Medicine Market Attractiveness Analysis, By End-User
10. Global Veterinary Medicine Market Analysis and Forecast, By Application
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Veterinary Medicine Market Value Share Analysis, By Application
10.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Application
10.5. Global Veterinary Medicine Market Analysis, By Application
10.6. Global Veterinary Medicine Market Attractiveness Analysis, By Application
11. Global Veterinary Medicine Market Analysis, by Region
11.1. Global Veterinary Medicine Market Value Share Analysis, by Region
11.2. Global Veterinary Medicine Market Size (US$ Bn) Forecast, by Region
11.3. Global Veterinary Medicine Market Attractiveness Analysis, by Region
12. North America Veterinary Medicine Market Analysis
12.1. Key Findings
12.2. North America Veterinary Medicine Market Overview
12.3. North America Veterinary Medicine Market Value Share Analysis, By Product
12.4. North America Veterinary Medicine Market Forecast, By Product
12.4.1. Drugs
12.4.1.1. Anti-infectives
12.4.1.2. Anti-inflammatory
12.4.1.3. Parasiticides
12.4.2. Vaccines
12.4.2.1. Inactivated Vaccines
12.4.2.2. Attenuated Vaccines
12.4.2.3. Recombinant Vaccines
12.4.3. Medicated Feed Additives
12.4.3.1. Amino acids
12.4.3.2. Antibiotics
12.5. North America Veterinary Medicine Market Value Share Analysis, By Route of Administration
12.6. North America Veterinary Medicine Market Forecast, By Route of Administration
12.6.1. Oral
12.6.2. Parenteral
12.6.3. Topical
12.7. North America Veterinary Medicine Market Value Share Analysis, By End-User
12.8. North America Veterinary Medicine Market Forecast, By End-User
12.8.1. Veterinary Hospital
12.8.2. Veterinary Clinics
12.8.3. Pharmacies & Drug Stores
12.9. North America Veterinary Medicine Market Value Share Analysis, By Application
12.10. North America Veterinary Medicine Market Forecast, By Application
12.10.1. Companion Animals
12.10.2. Livestock Animals
12.11. North America Veterinary Medicine Market Value Share Analysis, by Country
12.12. North America Veterinary Medicine Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Veterinary Medicine Market Analysis, by Country
12.14. U.S. Veterinary Medicine Market Forecast, By Product
12.14.1. Drugs
12.14.1.1. Anti-infectives
12.14.1.2. Anti-inflammatory
12.14.1.3. Parasiticides
12.14.2. Vaccines
12.14.2.1. Inactivated Vaccines
12.14.2.2. Attenuated Vaccines
12.14.2.3. Recombinant Vaccines
12.14.3. Medicated Feed Additives
12.14.3.1. Amino acids
12.14.3.2. Antibiotics
12.15. U.S. Veterinary Medicine Market Forecast, By Route of Administration
12.15.1. Oral
12.15.2. Parenteral
12.15.3. Topical
12.16. U.S. Veterinary Medicine Market Forecast, By End-User
12.16.1. Veterinary Hospital
12.16.2. Veterinary Clinics
12.16.3. Pharmacies & Drug Stores
12.17. U.S. Veterinary Medicine Market Forecast, By Application
12.17.1. Companion Animals
12.17.2. Livestock Animals
12.18. Canada Veterinary Medicine Market Forecast, By Product
12.18.1. Drugs
12.18.1.1. Anti-infectives
12.18.1.2. Anti-inflammatory
12.18.1.3. Parasiticides
12.18.2. Vaccines
12.18.2.1. Inactivated Vaccines
12.18.2.2. Attenuated Vaccines
12.18.2.3. Recombinant Vaccines
12.18.3. Medicated Feed Additives
12.18.3.1. Amino acids
12.18.3.2. Antibiotics
12.19. Canada Veterinary Medicine Market Forecast, By Route of Administration
12.19.1. Oral
12.19.2. Parenteral
12.19.3. Topical
12.20. Canada Veterinary Medicine Market Forecast, By End-User
12.20.1. Veterinary Hospital
12.20.2. Veterinary Clinics
12.20.3. Pharmacies & Drug Stores
12.21. Canada Veterinary Medicine Market Forecast, By Application
12.21.1. Companion Animals
12.21.2. Livestock Animals
12.22. North America Veterinary Medicine Market Attractiveness Analysis
12.22. North America Veterinary Medicine Market Attractiveness Analysis
12.22.1. By Product
12.22.2. By Route of Administration
12.22.3. By End-User
12.22.4. By Application
12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments
13. Europe Veterinary Medicine Market Analysis
13.1. Key Findings
13.2. Europe Veterinary Medicine Market Overview
13.3. Europe Veterinary Medicine Market Value Share Analysis, By Product
13.4. Europe Veterinary Medicine Market Forecast, By Product
13.4.1. Drugs
13.4.1.1. Anti-infectives
13.4.1.2. Anti-inflammatory
13.4.1.3. Parasiticides
13.4.2. Vaccines
13.4.2.1. Inactivated Vaccines
13.4.2.2. Attenuated Vaccines
13.4.2.3. Recombinant Vaccines
13.4.3. Medicated Feed Additives
13.4.3.1. Amino acids
13.4.3.2. Antibiotics
13.5. Europe Veterinary Medicine Market Value Share Analysis, By Route of Administration
13.6. Europe Veterinary Medicine Market Forecast, By Route of Administration
13.6.1. Oral
13.6.2. Parenteral
13.6.3. Topical
13.7. Europe Veterinary Medicine Market Value Share Analysis, By End-User
13.8. Europe Veterinary Medicine Market Forecast, By End-User
13.8.1. Veterinary Hospital
13.8.2. Veterinary Clinics
13.8.3. Pharmacies & Drug Stores
13.9. Europe Veterinary Medicine Market Value Share Analysis, By Application
13.10. Europe Veterinary Medicine Market Forecast, By Application
13.10.1. Companion Animals
13.10.2. Livestock Animals
13.11. Europe Veterinary Medicine Market Value Share Analysis, by Country
13.12. Europe Veterinary Medicine Market Forecast, by Country
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Europe Veterinary Medicine Market Analysis, by Country
13.14. Germany Veterinary Medicine Market Forecast, By Product
13.14.1. Drugs
13.14.1.1. Anti-infectives
13.14.1.2. Anti-inflammatory
13.14.1.3. Parasiticides
13.14.2. Vaccines
13.14.2.1. Inactivated Vaccines
13.14.2.2. Attenuated Vaccines
13.14.2.3. Recombinant Vaccines
13.14.3. Medicated Feed Additives
13.14.3.1. Amino acids
13.14.3.2. Antibiotics
13.15. Germany Veterinary Medicine Market Forecast, By Route of Administration
13.15.1. Oral
13.15.2. Parenteral
13.15.3. Topical
13.16. Germany Veterinary Medicine Market Forecast, By End-User
13.16.1. Veterinary Hospital
13.16.2. Veterinary Clinics
13.16.3. Pharmacies & Drug Stores
13.17. Germany Veterinary Medicine Market Forecast, By Application
13.17.1. Companion Animals
13.17.2. Livestock Animals
13.18. U.K. Veterinary Medicine Market Forecast, By Product
13.18.1. Drugs
13.18.1.1. Anti-infectives
13.18.1.2. Anti-inflammatory
13.18.1.3. Parasiticides
13.18.2. Vaccines
13.18.2.1. Inactivated Vaccines
13.18.2.2. Attenuated Vaccines
13.18.2.3. Recombinant Vaccines
13.18.3. Medicated Feed Additives
13.18.3.1. Amino acids
13.18.3.2. Antibiotics
13.19. U.K. Veterinary Medicine Market Forecast, By Route of Administration
13.19.1. Oral
13.19.2. Parenteral
13.19.3. Topical
13.20. U.K. Veterinary Medicine Market Forecast, By End-User
13.20.1. Veterinary Hospital
13.20.2. Veterinary Clinics
13.20.3. Pharmacies & Drug Stores
13.21. U.K. Veterinary Medicine Market Forecast, By Application
13.21.1. Companion Animals
13.21.2. Livestock Animals
13.22. France Veterinary Medicine Market Forecast, By Product
13.22.1. Drugs
13.22.1.1. Anti-infectives
13.22.1.2. Anti-inflammatory
13.22.1.3. Parasiticides
13.22.2. Vaccines
13.22.2.1. Inactivated Vaccines
13.22.2.2. Attenuated Vaccines
13.22.2.3. Recombinant Vaccines
13.22.3. Medicated Feed Additives
13.22.3.1. Amino acids
13.22.3.2. Antibiotics
13.23. France Veterinary Medicine Market Forecast, By Route of Administration
13.23.1. Oral
13.23.2. Parenteral
13.23.3. Topical
13.24. France Veterinary Medicine Market Forecast, By End-User
13.24.1. Veterinary Hospital
13.24.2. Veterinary Clinics
13.24.3. Pharmacies & Drug Stores
13.25. France Veterinary Medicine Market Forecast, By Application
13.25.1. Companion Animals
13.25.2. Livestock Animals
13.26. Italy Veterinary Medicine Market Forecast, By Product
13.26.1. Drugs
13.26.1.1. Anti-infectives
13.26.1.2. Anti-inflammatory
13.26.1.3. Parasiticides
13.26.2. Vaccines
13.26.2.1. Inactivated Vaccines
13.26.2.2. Attenuated Vaccines
13.26.2.3. Recombinant Vaccines
13.26.3. Medicated Feed Additives
13.26.3.1. Amino acids
13.26.3.2. Antibiotics
13.27. Italy Veterinary Medicine Market Forecast, By Route of Administration
13.27.1. Oral
13.27.2. Parenteral
13.27.3. Topical
13.28. Italy Veterinary Medicine Market Forecast, By End-User
13.28.1. Veterinary Hospital
13.28.2. Veterinary Clinics
13.28.3. Pharmacies & Drug Stores
13.29. Italy Veterinary Medicine Market Forecast, By Application
13.29.1. Companion Animals
13.29.2. Livestock Animals
13.30. Spain Veterinary Medicine Market Forecast, By Product
13.30.1. Drugs
13.30.1.1. Anti-infectives
13.30.1.2. Anti-inflammatory
13.30.1.3. Parasiticides
13.30.2. Vaccines
13.30.2.1. Inactivated Vaccines
13.30.2.2. Attenuated Vaccines
13.30.2.3. Recombinant Vaccines
13.30.3. Medicated Feed Additives
13.30.3.1. Amino acids
13.30.3.2. Antibiotics
13.31. Spain Veterinary Medicine Market Forecast, By Route of Administration
13.31.1. Oral
13.31.2. Parenteral
13.31.3. Topical
13.32. Spain Veterinary Medicine Market Forecast, By End-User
13.32.1. Veterinary Hospital
13.32.2. Veterinary Clinics
13.32.3. Pharmacies & Drug Stores
13.33. Spain Veterinary Medicine Market Forecast, By Application
13.33.1. Companion Animals
13.33.2. Livestock Animals
13.34. Rest of Europe Veterinary Medicine Market Forecast, By Product
13.34.1. Drugs
13.34.1.1. Anti-infectives
13.34.1.2. Anti-inflammatory
13.34.1.3. Parasiticides
13.34.2. Vaccines
13.34.2.1. Inactivated Vaccines
13.34.2.2. Attenuated Vaccines
13.34.2.3. Recombinant Vaccines
13.34.3. Medicated Feed Additives
13.34.3.1. Amino acids
13.34.3.2. Antibiotics
13.35. Rest of Europe Veterinary Medicine Market Forecast, By Route of Administration
13.35.1. Oral
13.35.2. Parenteral
13.35.3. Topical
13.36. Rest of Europe Veterinary Medicine Market Forecast, By End-User
13.36.1. Veterinary Hospital
13.36.2. Veterinary Clinics
13.36.3. Pharmacies & Drug Stores
13.37. Rest Of Europe Veterinary Medicine Market Forecast, By Application
13.37.1. Companion Animals
13.37.2. Livestock Animals
13.38. Europe Veterinary Medicine Market Attractiveness Analysis
13.38.1. By Product
13.38.2. By Route of Administration
13.38.3. By End-User
13.38.4. By Application
13.39. PEST Analysis
13.40. Key Trends
13.41. Key Developments
14. Asia Pacific Veterinary Medicine Market Analysis
14.1. Key Findings
14.2. Asia Pacific Veterinary Medicine Market Overview
14.3. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Product
14.4. Asia Pacific Veterinary Medicine Market Forecast, By Product
14.4.1. Drugs
14.4.1.1. Anti-infectives
14.4.1.2. Anti-inflammatory
14.4.1.3. Parasiticides
14.4.2. Vaccines
14.4.2.1. Inactivated Vaccines
14.4.2.2. Attenuated Vaccines
14.4.2.3. Recombinant Vaccines
14.4.3. Medicated Feed Additives
14.4.3.1. Amino acids
14.4.3.2. Antibiotics
14.5. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Route of Administration
14.6. Asia Pacific Veterinary Medicine Market Forecast, By Route of Administration
14.6.1. Oral
14.6.2. Parenteral
14.6.3. Topical
14.7. Asia Pacific Veterinary Medicine Market Value Share Analysis, By End-User
14.8. Asia Pacific Veterinary Medicine Market Forecast, By End-User
14.8.1. Veterinary Hospital
14.8.2. Veterinary Clinics
14.8.3. Pharmacies & Drug Stores
14.9. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Application
14.10. Asia Pacific Veterinary Medicine Market Forecast, By Application
14.10.1. Companion Animals
14.10.2. Livestock Animals
14.11. Asia Pacific Veterinary Medicine Market Value Share Analysis, by Country
14.12. Asia Pacific Veterinary Medicine Market Forecast, by Country
14.12.1. China
14.12.2. India
14.12.3. Japan
14.12.4. ASEAN
14.12.5. Rest of Asia Pacific
14.13. Asia Pacific Veterinary Medicine Market Analysis, by Country
14.14. China Veterinary Medicine Market Forecast, By Product
14.14.1. Drugs
14.14.1.1. Anti-infectives
14.14.1.2. Anti-inflammatory
14.14.1.3. Parasiticides
14.14.2. Vaccines
14.14.2.1. Inactivated Vaccines
14.14.2.2. Attenuated Vaccines
14.14.2.3. Recombinant Vaccines
14.14.3. Medicated Feed Additives
14.14.3.1. Amino acids
14.14.3.2. Antibiotics
14.15. China Veterinary Medicine Market Forecast, By Route of Administration
14.15.1. Oral
14.15.2. Parenteral
14.15.3. Topical
14.16. China Veterinary Medicine Market Forecast, By End-User
14.16.1. Veterinary Hospital
14.16.2. Veterinary Clinics
14.16.3. Pharmacies & Drug Stores
14.17. China Veterinary Medicine Market Forecast, By Application
14.17.1. Companion Animals
14.17.2. Livestock Animals
14.18. India Veterinary Medicine Market Forecast, By Product
14.18.1. Drugs
14.18.1.1. Anti-infectives
14.18.1.2. Anti-inflammatory
14.18.1.3. Parasiticides
14.18.2. Vaccines
14.18.2.1. Inactivated Vaccines
14.18.2.2. Attenuated Vaccines
14.18.2.3. Recombinant Vaccines
14.18.3. Medicated Feed Additives
14.18.3.1. Amino acids
14.18.3.2. Antibiotics
14.19. India Veterinary Medicine Market Forecast, By Route of Administration
14.19.1. Oral
14.19.2. Parenteral
14.19.3. Topical
14.20. India Veterinary Medicine Market Forecast, By End-User
14.20.1. Veterinary Hospital
14.20.2. Veterinary Clinics
14.20.3. Pharmacies & Drug Stores
14.21. India Veterinary Medicine Market Forecast, By Application
14.21.1. Companion Animals
14.21.2. Livestock Animals
14.22. Japan Veterinary Medicine Market Forecast, By Product
14.22.1. Drugs
14.22.1.1. Anti-infectives
14.22.1.2. Anti-inflammatory
14.22.1.3. Parasiticides
14.22.2. Vaccines
14.22.2.1. Inactivated Vaccines
14.22.2.2. Attenuated Vaccines
14.22.2.3. Recombinant Vaccines
14.22.3. Medicated Feed Additives
14.22.3.1. Amino acids
14.22.3.2. Antibiotics
14.23. Japan Veterinary Medicine Market Forecast, By Route of Administration
14.23.1. Oral
14.23.2. Parenteral
14.23.3. Topical
14.24. Japan Veterinary Medicine Market Forecast, By End-User
14.24.1. Veterinary Hospital
14.24.2. Veterinary Clinics
14.24.3. Pharmacies & Drug Stores
14.25. Japan Veterinary Medicine Market Forecast, By Application
14.25.1. Companion Animals
14.25.2. Livestock Animals
14.26. ASEAN Veterinary Medicine Market Forecast, By Product
14.26.1. Drugs
14.26.1.1. Anti-infectives
14.26.1.2. Anti-inflammatory
14.26.1.3. Parasiticides
14.26.2. Vaccines
14.26.2.1. Inactivated Vaccines
14.26.2.2. Attenuated Vaccines
14.26.2.3. Recombinant Vaccines
14.26.3. Medicated Feed Additives
14.26.3.1. Amino acids
14.26.3.2. Antibiotics
14.27. ASEAN Veterinary Medicine Market Forecast, By Route of Administration
14.27.1. Oral
14.27.2. Parenteral
14.27.3. Topical
14.28. ASEAN Veterinary Medicine Market Forecast, By End-User
14.28.1. Veterinary Hospital
14.28.2. Veterinary Clinics
14.28.3. Pharmacies & Drug Stores
14.29. ASEAN Veterinary Medicine Market Forecast, By Application
14.29.1. Companion Animals
14.29.2. Livestock Animals
14.30. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Product
14.30.1. Drugs
14.30.1.1. Anti-infectives
14.30.1.2. Anti-inflammatory
14.30.1.3. Parasiticides
14.30.2. Vaccines
14.30.2.1. Inactivated Vaccines
14.30.2.2. Attenuated Vaccines
14.30.2.3. Recombinant Vaccines
14.30.3. Medicated Feed Additives
14.30.3.1. Amino acids
14.30.3.2. Antibiotics
14.31. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Route of Administration
14.31.1. Oral
14.31.2. Parenteral
14.31.3. Topical
14.32. Rest of Asia Pacific Veterinary Medicine Market Forecast, By End-User
14.32.1. Veterinary Hospital
14.32.2. Veterinary Clinics
14.32.3. Pharmacies & Drug Stores
14.33. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Application
14.33.1. Companion Animals
14.33.2. Livestock Animals
14.34. Asia Pacific Veterinary Medicine Market Attractiveness Analysis
14.34.1. By Product
14.34.2. By Route of Administration
14.34.3. By End-User
14.34.4. By Application
14.35. PEST Analysis
14.36. Key Trends
14.37. Key Developments
15. Middle East & Africa Veterinary Medicine Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Veterinary Medicine Market Overview
15.3. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Product
15.4. Middle East & Africa Veterinary Medicine Market Forecast, By Product
15.4.1. Drugs
15.4.1.1. Anti-infectives
15.4.1.2. Anti-inflammatory
15.4.1.3. Parasiticides
15.4.2. Vaccines
15.4.2.1. Inactivated Vaccines
15.4.2.2. Attenuated Vaccines
15.4.2.3. Recombinant Vaccines
15.4.3. Medicated Feed Additives
15.4.3.1. Amino acids
15.4.3.2. Antibiotics
15.5. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Route of Administration
15.6. Middle East & Africa Veterinary Medicine Market Forecast, By Route of Administration
15.6.1. Oral
15.6.2. Parenteral
15.6.3. Topical
15.7. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By End-User
15.8. Middle East & Africa Veterinary Medicine Market Forecast, By End-User
15.8.1. Veterinary Hospital
15.8.2. Veterinary Clinics
15.8.3. Pharmacies & Drug Stores
15.9. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Application
15.10. Middle East & Africa Veterinary Medicine Market Forecast, By Application
15.10.1. Companion Animals
15.10.2. Livestock Animals
15.11. Middle East & Africa Veterinary Medicine Market Value Share Analysis, by Country
15.12. Middle East & Africa Veterinary Medicine Market Forecast, by Country
15.12.1. GCC
15.12.2. South Africa
15.12.3. Rest of Middle East & Africa
15.13. Middle East & Africa Veterinary Medicine Market Analysis, by Country
15.14. GCC Veterinary Medicine Market Forecast, By Product
15.14.1. Drugs
15.14.1.1. Anti-infectives
15.14.1.2. Anti-inflammatory
15.14.1.3. Parasiticides
15.14.2. Vaccines
15.14.2.1. Inactivated Vaccines
15.14.2.2. Attenuated Vaccines
15.14.2.3. Recombinant Vaccines
15.14.3. Medicated Feed Additives
15.14.3.1. Amino acids
15.14.3.2. Antibiotics
15.15. GCC Veterinary Medicine Market Forecast, By Route of Administration
15.15.1. Oral
15.15.2. Parenteral
15.15.3. Topical
15.16. GCC Veterinary Medicine Market Forecast, By End-User
15.16.1. Veterinary Hospital
15.16.2. Veterinary Clinics
15.16.3. Pharmacies & Drug Stores
15.17. GCC Veterinary Medicine Market Forecast, By Application
15.17.1. Companion Animals
15.17.2. Livestock Animals
15.18. South Africa Veterinary Medicine Market Forecast, By Product
15.18.1. Drugs
15.18.1.1. Anti-infectives
15.18.1.2. Anti-inflammatory
15.18.1.3. Parasiticides
15.18.2. Vaccines
15.18.2.1. Inactivated Vaccines
15.18.2.2. Attenuated Vaccines
15.18.2.3. Recombinant Vaccines
15.18.3. Medicated Feed Additives
15.18.3.1. Amino acids
15.18.3.2. Antibiotics
15.19. South Africa Veterinary Medicine Market Forecast, By Route of Administration
15.19.1. Oral
15.19.2. Parenteral
15.19.3. Topical
15.20. South Africa Veterinary Medicine Market Forecast, By End-User
15.20.1. Veterinary Hospital
15.20.2. Veterinary Clinics
15.20.3. Pharmacies & Drug Stores
15.21. South Africa Veterinary Medicine Market Forecast, By Application
15.21.1. Companion Animals
15.21.2. Livestock Animals
15.22. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Product
15.22.1. Drugs
15.22.1.1. Anti-infectives
15.22.1.2. Anti-inflammatory
15.22.1.3. Parasiticides
15.22.2. Vaccines
15.22.2.1. Inactivated Vaccines
15.22.2.2. Attenuated Vaccines
15.22.2.3. Recombinant Vaccines
15.22.3. Medicated Feed Additives
15.22.3.1. Amino acids
15.22.3.2. Antibiotics
15.23. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Route of Administration
15.23.1. Oral
15.23.2. Parenteral
15.23.3. Topical
15.24. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By End-User
15.24.1. Veterinary Hospital
15.24.2. Veterinary Clinics
15.24.3. Pharmacies & Drug Stores
15.25. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Application
15.25.1. Companion Animals
15.25.2. Livestock Animals
15.26. Middle East & Africa Veterinary Medicine Market Attractiveness Analysis
15.26.1. By Product
15.26.2. By Route of Administration
15.26.3. By End-User
15.26.4. By Application
15.27. PEST Analysis
15.28. Key Trends
15.29. Key Developments
16. South America Veterinary Medicine Market Analysis
16.1. Key Findings
16.2. South America Veterinary Medicine Market Overview
16.3. South America Veterinary Medicine Market Value Share Analysis, By Product
16.4. South America Veterinary Medicine Market Forecast, By Product
16.4.1. Drugs
16.4.1.1. Anti-infectives
16.4.1.2. Anti-inflammatory
16.4.1.3. Parasiticides
16.4.2. Vaccines
16.4.2.1. Inactivated Vaccines
16.4.2.2. Attenuated Vaccines
16.4.2.3. Recombinant Vaccines
16.4.3. Medicated Feed Additives
16.4.3.1. Amino acids
16.4.3.2. Antibiotics
16.5. South America Veterinary Medicine Market Value Share Analysis, By Route of Administration
16.6. South America Veterinary Medicine Market Forecast, By Route of Administration
16.6.1. Oral
16.6.2. Parenteral
16.6.3. Topical
16.7. South America Veterinary Medicine Market Value Share Analysis, By End-User
16.8. South America Veterinary Medicine Market Forecast, By End-User
16.8.1. Veterinary Hospital
16.8.2. Veterinary Clinics
16.8.3. Pharmacies & Drug Stores
16.9. South America Veterinary Medicine Market Value Share Analysis, By Application
16.10. South America Veterinary Medicine Market Forecast, By Application
16.10.1. Companion Animals
16.10.2. Livestock Animals
16.11. South America Veterinary Medicine Market Value Share Analysis, by Country
16.12. South America Veterinary Medicine Market Forecast, by Country
16.12.1. Brazil
16.12.2. Mexico
16.12.3. Rest of South America
16.13. South America Veterinary Medicine Market Analysis, by Country
16.14. Brazil Veterinary Medicine Market Forecast, By Product
16.14.1. Drugs
16.14.1.1. Anti-infectives
16.14.1.2. Anti-inflammatory
16.14.1.3. Parasiticides
16.14.2. Vaccines
16.14.2.1. Inactivated Vaccines
16.14.2.2. Attenuated Vaccines
16.14.2.3. Recombinant Vaccines
16.14.3. Medicated Feed Additives
16.14.3.1. Amino acids
16.14.3.2. Antibiotics
16.15. Brazil Veterinary Medicine Market Forecast, By Route of Administration
16.15.1. Oral
16.15.2. Parenteral
16.15.3. Topical
16.16. Brazil Veterinary Medicine Market Forecast, By End-User
16.16.1. Veterinary Hospital
16.16.2. Veterinary Clinics
16.16.3. Pharmacies & Drug Stores
16.17. Brazil Veterinary Medicine Market Forecast, By Application
16.17.1. Companion Animals
16.17.2. Livestock Animals
16.18. Mexico Veterinary Medicine Market Forecast, By Product
16.18.1. Drugs
16.18.1.1. Anti-infectives
16.18.1.2. Anti-inflammatory
16.18.1.3. Parasiticides
16.18.2. Vaccines
16.18.2.1. Inactivated Vaccines
16.18.2.2. Attenuated Vaccines
16.18.2.3. Recombinant Vaccines
16.18.3. Medicated Feed Additives
16.18.3.1. Amino acids
16.18.3.2. Antibiotics
16.19. Mexico Veterinary Medicine Market Forecast, By Route of Administration
16.19.1. Oral
16.19.2. Parenteral
16.19.3. Topical
16.20. Mexico Veterinary Medicine Market Forecast, By End-User
16.20.1. Veterinary Hospital
16.20.2. Veterinary Clinics
16.20.3. Pharmacies & Drug Stores
16.21. Mexico Veterinary Medicine Market Forecast, By Application
16.21.1. Companion Animals
16.21.2. Livestock Animals
16.22. Rest of South America Veterinary Medicine Market Forecast, By Product
16.22.1. Drugs
16.22.1.1. Anti-infectives
16.22.1.2. Anti-inflammatory
16.22.1.3. Parasiticides
16.22.2. Vaccines
16.22.2.1. Inactivated Vaccines
16.22.2.2. Attenuated Vaccines
16.22.2.3. Recombinant Vaccines
16.22.3. Medicated Feed Additives
16.22.3.1. Amino acids
16.22.3.2. Antibiotics
16.23. Rest of South America Veterinary Medicine Market Forecast, By Route of Administration
16.23.1. Oral
16.23.2. Parenteral
16.23.3. Topical
16.24. Rest of South America Veterinary Medicine Market Forecast, By End-User
16.24.1. Veterinary Hospital
16.24.2. Veterinary Clinics
16.24.3. Pharmacies & Drug Stores
16.25. Rest of South America Veterinary Medicine Market Forecast, By Application
16.25.1. Companion Animals
16.25.2. Livestock Animals
16.26. South America Veterinary Medicine Market Attractiveness Analysis
16.26.1. By Product
16.26.2. By Route of Administration
16.26.3. By End-User
16.26.4. By Application
16.27. PEST Analysis
16.28. Key Trends
16.29. Key Developments
17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
17.2.2. New Product Launches and Product Enhancements
17.2.3. Market Consolidation
17.2.3.1. M&A by Regions, Investment and Applications
17.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
17.3. Company Profiles: Key Players
17.3.1. Agrovet Market Animal Health
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategy
17.3.1.5. Recent Developments
17.3.1.6. Development Footprint
17.3.2. American Veterinary Clinic
17.3.3. Animalcare
17.3.4. BASF India Ltd
17.3.5. Belfarmacom
17.3.6. Bimeda
17.3.7. Biotex Plus Ltd
17.3.8. Boehringer Ingelheim Gmbh
17.3.9. Brouwer
17.3.10. Cadila Pharmaceuticals Ltd
17.3.11. Cargill India Pvt. Ltd
17.3.12. Ceva
17.3.13. Chemo Argentina
17.3.14. Koninklijke DSM N.V
17.3.15. Mars
17.3.16. Merck & Co.
17.3.17. Saudi Pharmaceutical Industries
17.3.18. Sauvet
17.3.19. Selecta
17.3.20. Syntec
17.3.21. The British Veterinary Center
17.3.22. UCBVET
17.3.23. Vetanco
17.3.24. Veterinarski Zavod Subotica
17.3.25. Vetmedica
17.3.26. Wageningen Bioveterinary Research
17.3.27. Wilbur-Ellis
17.3.28. Zoetis
18. Primary Key Insights